- Home
- ELEV vs MTEX Comparison
ELEV vs MTEX Comparison
Compare ELEV & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- MTEX
- Stock Information
- Founded
- ELEV 2019
- MTEX 1993
- Country
- ELEV United States
- MTEX United States
- Employees
- ELEV N/A
- MTEX N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- ELEV Health Care
- MTEX Health Care
- Exchange
- ELEV Nasdaq
- MTEX Nasdaq
- Market Cap
- ELEV 20.0M
- MTEX 19.9M
- IPO Year
- ELEV 2021
- MTEX 1999
- Fundamental
- Price
- ELEV $0.34
- MTEX $11.79
- Analyst Decision
- ELEV Buy
- MTEX
- Analyst Count
- ELEV 6
- MTEX 0
- Target Price
- ELEV $2.94
- MTEX N/A
- AVG Volume (30 Days)
- ELEV 975.2K
- MTEX 1.0K
- Earning Date
- ELEV 05-23-2025
- MTEX 05-13-2025
- Dividend Yield
- ELEV N/A
- MTEX N/A
- EPS Growth
- ELEV N/A
- MTEX N/A
- EPS
- ELEV N/A
- MTEX N/A
- Revenue
- ELEV N/A
- MTEX $115,036,000.00
- Revenue This Year
- ELEV N/A
- MTEX N/A
- Revenue Next Year
- ELEV N/A
- MTEX N/A
- P/E Ratio
- ELEV N/A
- MTEX N/A
- Revenue Growth
- ELEV N/A
- MTEX N/A
- 52 Week Low
- ELEV $0.22
- MTEX $6.75
- 52 Week High
- ELEV $4.33
- MTEX $16.49
- Technical
- Relative Strength Index (RSI)
- ELEV 48.18
- MTEX 65.65
- Support Level
- ELEV $0.33
- MTEX $9.70
- Resistance Level
- ELEV $0.37
- MTEX $11.97
- Average True Range (ATR)
- ELEV 0.03
- MTEX 0.34
- MACD
- ELEV 0.00
- MTEX 0.15
- Stochastic Oscillator
- ELEV 25.54
- MTEX 92.07
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.